4//SEC Filing
TARNOW MICHAEL M 4
Accession 0001209191-20-056229
CIK 0001582313other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 4:27 PM ET
Size
12.6 KB
Accession
0001209191-20-056229
Insider Transaction Report
Form 4
TARNOW MICHAEL M
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-10-28−5,144→ 0 totalExercise: $3.76Exp: 2020-12-31→ Common Shares (5,144 underlying) - Exercise/Conversion
Common Shares
2020-10-28$3.76/sh+5,144$19,341→ 74,857 total - Exercise/Conversion
Common Shares
2020-10-28$3.76/sh+5,144$19,341→ 80,001 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-10-28−5,144→ 0 totalExercise: $3.76Exp: 2020-12-31→ Common Shares (5,144 underlying) - Gift
Common Shares
2020-10-28−10,288→ 69,713 total
Footnotes (3)
- [F1]The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.
- [F2]The shares were gifted to family members that do not share the reporting person's household.
- [F3]The shares subject to the option fully vested on December 31, 2013. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001263647
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 4:27 PM ET
- Size
- 12.6 KB